Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Adverse events from compounded semaglutide have led to hundreds of hospitalizations, highlighting critical safety concerns for healthcare providers managing patients seeking weight loss solutions.
Endocrinology, Diabetes, Metabolism November 20th 2024
MedCentral
The FDA-designated Class II recall affects specific duloxetine lots where exposure may lead to “temporary or medically reversible health consequences or where the probability of serious adverse health consequences is remote.”
Clinical Pharmacology November 20th 2024
SingleCare
Current evidence indicates that while digestive and energy improvements may manifest within one week, longer-term benefits require extended supplementation periods and careful monitoring of iodine levels.
Endocrinology, Diabetes, Metabolism November 11th 2024
“Doctors must make difficult judgment calls to protect patients, even if it yields an unwanted outcome,” says attorney Denzell Moton, highlighting the complex nature of medical decision-making in critical situations.
Emergency Medicine October 8th 2024
In Utah, any licensed physician with some general surgical or plastic surgery training can perform cosmetic plastic surgery, regardless of board certification status.
Dermatology September 24th 2024
Medical errors are now recognized as the third leading cause of death in the US, emphasizing the urgent need for improved safety measures in healthcare settings.
Anesthesiology September 10th 2024